TAK vs MSFT: Which Stock is Better?
Side-by-side comparison of Takeda Pharmaceutical Co Ltd and Microsoft Corp in 2026
TAK
Takeda Pharmaceutical Co Ltd
$17.78
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | TAK | MSFT | Winner |
|---|---|---|---|
| Market Cap | $56.39B | N/A | TAK |
| P/E Ratio | 81.14 | 26.32 | MSFT |
| EPS (TTM) | $0.22 | $15.97 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 65.5% | 68.6% | MSFT |
Analyze TAK
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TAK or MSFT a better investment?
Comparing TAK and MSFT: Takeda Pharmaceutical Co Ltd has a market cap of $56.39B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TAK and MSFT?
TAK (Takeda Pharmaceutical Co Ltd) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TAK or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (26.3x vs 81.1x).
Which is growing faster: TAK or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for TAK.
Which company is more profitable: TAK or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 65.5% for TAK.
Which is the larger company: TAK or MSFT?
Takeda Pharmaceutical Co Ltd (TAK) is larger with a market cap of $56.39B compared to N/A for MSFT.
Should I buy TAK or MSFT in 2026?
Both TAK and MSFT have investment merit. TAK trades at $17.78 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TAK and MSFT stock?
Key differences: Market Cap ($56.39B vs N/A), P/E Ratio (81.1x vs 26.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (65.5% vs 68.6%).